Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 643
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05797740 Cladribine Tablets Level of Response Predictors in Clinical Practice (C… |
Mavenclad | SEP | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Healthcare KGaA, Darmstadt,… | Belgium, Czechia, Greece, Netherlands, Poland, Portug… | 2023-08-03 → 2029-01-31 | Ouvrir |
| NCT05998616 FERLAMS — Feasibility of Remote Exercise Training for Hispanics/Latinos… |
FERLAMS — Feasibility of Remote E… | SEP | Non applicable | TERMINATED | En attente / non publié | University of Illinois at Chicago | United States · University of Illinois at Chicago, Ch… | 2024-04-27 → 2025-12-31 | Ouvrir |
| NCT07168772 PROBiMS — The Effect of a Probiotic Administration as an add-on Treatme… |
PROBiMS — The Effect of a Probiot… | SEP | Non applicable | RECRUITING | En attente / non publié | Hospital Universitari Vall d'Hebr… | Spain · Centre d'Esclerosi Mútiple de Catalunya (Cemc… | 2025-07-10 → 2027-12-31 | Ouvrir |
| NCT06869785 FILIOS — Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of… |
Ofatumumab approved dose | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Puerto Rico · Advent Neurology Clinic,… | 2025-03-13 → 2030-03-23 | Ouvrir |
| NCT06451159 A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Tre… |
KYV-101 (Biological) - 0.33 ×10^8… | SEP | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Bruce Cree | United States · University of California, San Francis… | 2024-06-20 → 2027-02 | Ouvrir |
| NCT01892722 Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple S… |
Interferon beta-1a | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | German University in Cairo | United States, Australia, Austria, Brazil, Bulgaria, … | 2013-07-26 → 2030-02-18 | Ouvrir |
| NCT05658497 Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate) |
Diroximel Fumarate | SEP | À vérifier | RECRUITING | En attente / non publié | Biogen | United States, Australia, Germany, Ireland, Spain, Sw… | 2023-10-27 → 2032-07-06 | Ouvrir |
| NCT04565431 Examining Effects of Tysabri on Cognitive Fatigue Using fMRI |
Tysabri | SEP | À vérifier | COMPLETED | En attente / non publié | Kessler Foundation | United States · Kessler Foundation, West Orange, Unit… | 2021-03-19 → 2025-12-15 | Ouvrir |
| NCT07757568 Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dim… |
Vumerity | SEP | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | University of Colorado, Denver | United States · University of Colorado, Denver, Auror… | 2023-03-07 → 2026-11-07 | Ouvrir |
| NCT05232825 Ocarina II — A Phase III, Non-Inferiority, Randomized, Open-Label, Para… |
Ocrelizumab IV | SEP | Phase 3 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States, Brazil, Czechia, Italy, New Zealand, P… | 2022-05-03 → 2025-06-06 | Ouvrir |
| NCT05837949 MS FIT — Multiple Sclerosis Falls Insight Track |
MS FIT — Multiple Sclerosis Falls… | SEP | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | University of California, San Fra… | United States · University of California, San Francis… | 2023-04-12 → 2026-09-01 | Ouvrir |
| NCT04448977 Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI |
Ocrevus | SEP | À vérifier | COMPLETED | En attente / non publié | State University of New York at B… | United States · Kessler Foundation, West Orange, Unit… | 2021-05-06 → 2025-10-15 | Ouvrir |
| NCT07758270 REDIFINE MS — Brain Imaging and Immune Changes During Remibrutinib Trea… |
Remibrutinib | SEP | À vérifier | RECRUITING | En attente / non publié | Washington University School of M… | United States · Washington University School of Medic… | 2026-08-15 → 2030-08-29 | Ouvrir |
| NCT07759115 Music-4-MS to Improve Cognition in People Living With Multiple Sclerosi… |
Music-4-MS to Improve Cognition i… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Texas at Austin | United States · University of Texas at Austin, Austin… | 2026-08 → 2028-08 | Ouvrir |
| NCT06444113 KATHAROS — Concentration of Ofatumumab in the Breast Milk of Lactating … |
Ofatunumab | SEP | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Germany, Italy, Poland, United Kingdom… | 2024-11-25 → 2026-10-29 | Ouvrir |
| NCT07111637 AssistMS — Artificial Intelligence-Assisted Magnetic Resonance Imaging … |
AI software | SEP | Non applicable | RECRUITING | En attente / non publié | Queen Mary University of London | United Kingdom · Barts Health NHS Trust, London, Unit… | 2025-06-14 → 2027-04-14 | Ouvrir |
| NCT07762040 RRMS — Predictors of Progression Independent of Relapse Activity in Rel… |
RRMS — Predictors of Progression … | SEP | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Egypt · Assiut university neurology hospital, Asyut, … | 2026-09-01 → 2028-12-01 | Ouvrir |
| NCT06800144 Effect of Music Therapy on Pain in People With Multiple Sclerosis |
Effect of Music Therapy on Pain i… | SEP | Non applicable | COMPLETED | En attente / non publié | Istanbul Bilgi University | Turkey (Türkiye) · Istanbul Bilgi University, Istanbu… | 2026-03-01 → 2026-08-12 | Ouvrir |
| NCT07762326 Effect of Artificial Intelligence Based Cognitive Training on Sleep Dis… |
Effect of Artificial Intelligence… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Cairo University | Non communiqué | 2026-08-20 → 2027-03-30 | Ouvrir |
| NCT06957145 Vista Protein Expression of Monocyte and T Cell Subsets in Multiple Scl… |
Vista Protein Expression of Monoc… | SEP | À vérifier | COMPLETED | En attente / non publié | Koç University | Turkey (Türkiye) · Bakirkoy Prof. Dr. Mazhar Osman Tr… | 2025-06-30 → 2026-08-12 | Ouvrir |
| NCT05357833 Novel Imaging Markers in SPMS |
Ferumoxytol infusion | SEP | Phase 1 | COMPLETED | En attente / non publié | University of Utah | United States · University of Utah Health Imaging and… | 2022-06-01 → 2023-09-01 | Ouvrir |
| NCT06780150 SurfSubQ — A Study to Investigate Effects of Ocrelizumab Treatment on N… |
Ocrelizumab | SEP | À vérifier | RECRUITING | En attente / non publié | Hoffmann-La Roche | Germany, Switzerland · Allgemeines Krankenhaus Celle … | 2024-09-26 → 2028-03-31 | Ouvrir |
| NCT07667322 OCARINA 3 — A Study to Investigate the Safety, Tolerability, Pharmacoki… |
Ocrelizumab Co-formulated With rH… | SEP | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Brazil, Mexico, United Kingdom · Centr… | 2024-12-17 → 2028-08-01 | Ouvrir |
| NCT07051525 ELSA-Adult — Early Versus Late Stopping of Antibiotics in Adults With H… |
Early antibiotic cessation alert | Cancer | NA | RECRUITING | En attente / non publié | Peter MacCallum Cancer Centre, Au… | Australia · Peter MacCallum Cancer Centre, Melbourne,… | 2025-12-03 → 2028-02-05 | Ouvrir |
| NCT07606521 A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-l… |
US-Ocrevus | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Polpharma Biologics International… | Non communiqué | 2026-10 → 2028-04 | Ouvrir |